Skip to main content

Tag: Europe

Comparing U.S. And European Cannabis Legalization

Starting in 2012 with Colorado and Washington State, jurisdictions in the U.S. began to modernize their cannabis policies to permit adult-use cannabis activity. In some cases, the reform efforts involved legalizing sales of recreational cannabis products. Today, two dozen states in the U.S. have adopted adult-use legalization, as well as Washington D.C.

In recent years, adult-use cannabis policy modernization has spread to the European continent. The first European nation to adopt a national recreational cannabis law was Malta in 2021, followed by Luxembourg in 2023 and Germany in 2024.

Earlier this year, lawmakers in the Czech Republic also adopted a national adult-use cannabis legalization measure, with the new law set to take effect on January 1st, 2026. A national adult-use cannabis legalization measure was recently introduced in Slovenia, and policymakers in Switzerland are also considering a national recreational legalization measure.

At the state level in the U.S., and the national level in Europe, no two legal jurisdictions have the same model. Every jurisdiction permits differing cultivation, possession, and commerce policies and regulations to some degree.

In the U.S., most legal cannabis states permit home cultivation, but not all of them. Washington State is a noteworthy example. Despite being one of the first legal states in the U.S., along with Colorado, Washington still prohibits adult-use home cannabis cultivation. Illinois also does not permit adult-use cultivation.

Additionally, most legal recreational jurisdictions in the U.S. permit adult-use cannabis product sales, but there are exceptions. Virginia allows legal adult-use cannabis possession, but not sales. Washington D.C. also permits personal adult-use activity, but not adult-use product sales.

Vermont was the first state in the U.S. to legalize via legislative action, and initially did not permit adult-use cannabis sales, but later modernized its adult-use model to permit sales. All the while, cannabis has remained a Schedule I substance at the federal level in the United States, and all adult-use activity is prohibited at the federal level, but ‘tolerated’ at the state and district levels.

A somewhat similar public policy scenario exists in Europe, where European Union agreements largely prohibit modernized adult-use cannabis policies and regulations, but do allow limited national-level legalization to proceed in some ways.

Current European Union agreements prohibit national adult-use product sales, like what is occurring in Canada and Uruguay, but do allow reform measures to be adopted by its member nations if they fall within research and ‘boosting public health outcome’ parameters.

Home cultivation is so far a standard component of adult-use legalization models in Europe. Malta, Luxembourg, and Germany all permit home cultivation by adults, and once Czechia’s legalization law takes effect, it will also allow home cultivation.

Limited adult-use commerce of non-cannabis light products occurs legally via two channels in Europe right now. The first is via cultivation associations, in which consumers become members of an association and source their cannabis products. Malta and Germany permit cultivation associations, but Luxembourg does not, and when Czechia’s law takes effect, it will also continue to prohibit cultivation associations.

The other EU-approved legal channel for recreational cannabis commerce is regional adult-use cannabis pilot trials. Pilot trials are already operating in the Netherlands and Switzerland, even though both nations have yet to adopt national legalization measures, and pilots are expected to launch someday in Germany too. The legalization models in Malta, Luxembourg, and Czechia do not include pilot trials.

One of the biggest differences between the United States and Europe’s adult-use policy modernization efforts is the way that they are described. Europe’s recent policy modernization models are often described as ‘decriminalization’ even though they would constitute ‘legalization’ in the United States.

The difference between how the two are described is often in the eye of the beholder. Many cannabis policy reformists in the United States do not consider policies to be true legalization unless they involve permitted home cultivation. Conversely, many advocates in Europe do not consider policies to be true legalization unless national adult-use sales are permitted.

My home state, Oregon, became the first state in the U.S. to adopt a cannabis decriminalization measure in 1973, removing the criminal charge associated with possessing a personal amount of cannabis and replacing the penalty with a fine.

Later, in 2014, voters in Oregon approved a measure that removed the fine and allowed adults to possess a personal amount of cannabis with no penalty at all. In my personal opinion, that is the difference between decriminalization and legalization, but I also respect the opinions of other longtime cannabis activists who feel differently.

I am hopeful that in the not-too-distant future, lawmakers on both sides of the Atlantic Ocean will adopt sensible, harmonized cannabis policies and regulations so that consumers and patients are protected, and the industry can reach its full potential.

Members Of European Parliament Push For Hemp Legal Framework

Hemp policies and regulations in Europe have historically been a patchwork of sorts, and that patchwork has resulted in a considerable amount of confusion and conflict. Arguably, the most noteworthy example of that can be found in Italy, where domestic lawmakers have adopted hemp policies that directly conflict with European Union policies.

Last month, lawmakers in Italy passed a ‘security decree’ measure that bans all processing, distribution, trade, and transport of ‘cultivated hemp inflorescences.’ Italy’s cannabis light sector currently employs an estimated 22,000 people.

The lack of harmonized continental hemp rules and regulations has created a lot of headaches for Europe’s industry members, including Europe’s farmers who want to cultivate a crop that is experiencing increased demand in Europe and around the world. A group of Members of the European Parliament (MEPs) is pushing for a legal framework to provide farmers with more certainty.

“Agriculture-focused MEPs are throwing their weight behind a push to secure EU rules on the cultivation of non-intoxicating cannabis – a move aimed at bypassing national restrictions on the taboo crop.” reported Euractiv in its original coverage.

“The European Parliament’s Agriculture Committee (AGRI) backed the move in its position on the next Common Agricultural Policy (CAP), adopted on Monday. Even though the demand on the European Commission isn’t binding, the text urges the executive to set an EU-wide classification for industrial hemp limiting tetrahydrocannabinol (THC) – the psychoactive component in cannabis – to a maximum of 0.5%.” the outlet also reported.

Maximum THC thresholds for hemp production vary around the globe, ranging from .2% THC to 2%. Exceeding a THC threshold for hemp harvests can result in farmers losing entire crops, which is obviously not optimal.

A better regulatory concept that was proposed by leading hemp expert Morris Beagle, President of We Are For Better Alternatives, during a panel discussion at the recent International Cannabis Business Conference in Berlin is to enforce a THC limit at the product level.

Rather than place the burden of meeting a THC limit on farmers, which is not an easy standard to meet given all of the variables involved, the burden to meet a THC threshold limit would instead be placed on product makers, which is considerably easier for them to do comparatively.

The push by members of the European Parliament’s Agriculture Committee may not be binding, but it is still a welcome endorsement for an industry that is trying to strike the right balance between addressing reasonable concerns and being able to operate in an environment that isn’t constantly shifting.

European Industrial Hemp Association Announces Leadership Change

The European Industrial Hemp Association (EIHA) is one of the most established, respected, and important organizations on the planet. EIHA is the only pan-European membership organization in the industrial hemp sector and represents the common interests of hemp farmers, producers, and traders working with hemp fibers, shives, seeds, oil, leaves, and cannabinoids.

The organization’s main task is to represent, serve, and protect the hemp sector in the European Union and international policymaking. EIHA focuses on the different areas of the application of hemp, including its use for textiles, construction materials, paper, cosmetics, feed, food, and supplements.

EIHA recently announced a big change in the organization’s leadership. Below is more information about the leadership change via a press release from the organization:

The European Industrial Hemp Association announces an important leadership change: Lorenza Romanese will be stepping down as Managing Director, and Francesco Mirizzi, currently Senior Policy Advisor at EIHA, will take over the role.

Mr Mirizzi has been part of the EIHA team for the past five years, where he has worked closely with members and stakeholders on all policy files. His expertise spans key dossiers such as feed, construction, food, and the Common Agricultural Policy (CAP) is especially timely, as these dossiers are currently in active development at the EU level. His leadership comes at a crucial moment and positions EIHA strongly for the next phase of advocacy and growth.

Ms Romanese, who has led EIHA since 2019, was instrumental in establishing the association’s Brussels presence and building up its influence at the EU level. Her strategic vision and relentless commitment over the past six years helped position hemp as a serious and growing sector in Europe. “It has been a privilege to lead EIHA through these transformative years. I am proud of what
we’ve achieved together. Francesco’s leadership comes at the right time—his topics are hot and his expertise unmatched. I’m not going far—I’ll continue to support Francesco, the board, and all of you as an advisor, especially on the Novel Food Consortium.” – she states.

While stepping back from the day-to-day role, Ms Romanese will remain involved with EIHA, as a senior advisor, continuing to support the Novel Food Consortium. She will stay on board part-time to advise on strategy and the next steps for the Novel Food applications in the EU and in the UK.

This announcement comes after the EIHA General Meeting on the 11th of June. While negotiations were already underway, Ms. Romanese was still in the middle of the transition process and no formal announcement was made. With everything now confirmed, we are pleased to share the news.

Monica Solano Leon will remain a central point of contact for members, continuing to handle administration, Consortium coordination, and general support. Monica’s continuity ensures stable operations and consistent communication for the entire EIHA network.

We welcome this change with optimism and trust you will receive it with the same enthusiasm as we do. Mr Mirizzi has our full confidence – his dedication, insight, and collaborative spirit have already proven invaluable, and we are eager to see his leadership in action. “I am honoured to step into this role and build on the incredible work Lorenza has done. As the policy landscape
evolves, EIHA must stay proactive, informed, and united. I look forward to working closely with our members and partners to strengthen our voice and impact in Brussels.” – Mr Mirizzi affirms. “In the coming year we will focus on clarifying once and for all the legal status of all parts of hemp, accelerating the Novel Food applications and further increasing awareness of the potential of hemp in the bioeconomy sector” – he adds.

We thank Ms Romanese warmly for her remarkable contributions over the past six years, and we look forward to continuing this journey with Mr Mirizzi leading the way.

An Estimated 8.4% Of European Adults Consume Cannabis

The European Union Drugs Agency (EUDA) recently published an updated analysis of cannabis use within the European continent. Based in Lisbon, Portugal, EUDA describes itself as “the leading authority on illicit drugs in Europe.”

“Cannabis is the most widely consumed illicit drug in Europe, with national surveys showing that an estimated 8.4 % of European adults (24 million aged 15 to 64) have used cannabis in the last year.” EUDA wrote in its ‘European Drug Report 2025‘. “The cannabis market accounts for the largest share of the overall illicit drug retail market in the European Union, with an estimated value of at least EUR 12.1 billion.”

“Around 1.5 % of adults in the European Union (4.3 million people) are estimated to be daily or almost daily cannabis consumers, and these people are most likely to experience problems associated with use of this drug.” the report also stated.

Cannabis is currently legal for adult use in Malta, Luxembourg, Germany, and, likely soon, the Czech Republic. Many more countries in Europe permit medical cannabis use, and several of those countries have legal medical cannabis industries.

“Seizures of cannabis products overall continued to be at historically high levels in 2023, confirming the high availability of this drug. However, the total quantity of cannabis resin seized in the European Union dropped significantly in 2022, largely due to a decrease in seizures reported by Spain, before slightly increasing again in 2023.” EUDA states in its report.

EUDA also determined the following:

  • Spain accounts for 68% of all resin seized, 30% of all herbal cannabis seized, and 73% of the total number of cannabis plants seized in the EU.
  • The average ‘resin sample’ of seized cannabis contains 23% THC
  • The European Commission has received 194 applications for CBD product authorization as a novel food since 2018
  • The most commonly encountered semi-synthetic cannabinoid is hexahydrocannabinol (HHC)
  • Males are “typically twice as likely to report use as females”
  • Only 45% of people entering treatment for cannabis use do so voluntarily
  • 615,000 cannabis use or possession offences were reported in the European Union in 2023

Additional context is worth considering regarding EUDA’s reported consumption rates. A vast majority of European nations still prohibit recreational cannabis use, and it is logical to conclude that many consumers are reluctant to admit using cannabis to government surveyors.

As such, the actual annual cannabis consumption rate for European adults could be greater than EUDA’s estimated 8.4%.

Discussing Advanced Cannabis Cultivation Technologies

Advanced cannabis cultivation has come a long way in recent years. Humans have cultivated the cannabis plant for centuries. However, much of it was outdoors under the sun without the use of technology.

In recent decades, cannabis cultivators have produced crops indoors or in greenhouses at an increasing rate, largely out of necessity due to global prohibition policies. The rise of the legal cannabis industry has been paralleled by an increased use of cultivation technology, as well as advances in that technology. It is truly exciting times for the legal cannabis cultivation sector.

Long gone are the days of simply yielding a cannabis harvest. Successful cultivation is more methodical than ever, with commercial cultivators having to produce harvests at scale in a cost-effective manner, all while being mindful of yielding crops that are compliant with market regulations and capable of being used in an ever-expanding list of end products for patients and consumers.

At the recent International Cannabis Business Conference in Berlin, a panel moderated by Quinn Shiskin, President of McIntyre Creek Cannabis Inc., discussed advanced cannabis cultivation technologies. Mr. Shiskin was joined by:

  • Franz Josef Sima, Horticulture Service Specialist in the EMEA Region for Fluence
  • Albert Eppinga, Entrepreneur and Philanthropist, Founder of BC Cann
  • Max Majot, Technical Manager and Cultivation Expert at Royal Queen Seeds
  • Rui Soares, Founder and CEO of Paralab
  • Mikhail Sagal, President of TSRgrow

Technological innovation is reshaping cannabis cultivation, from automated systems to AI-driven analytics. This panel explored how tech solutions can boost yields, improve quality, and reduce costs. Panelists also discussed modern ways of energy storage, innovations in cultivation lighting, and high-efficiency cannabis cultivation techniques. You can watch the panel at this link here.

European Cannabis Pilot Projects

Certain European markets are home to a unique public policy and commerce concept known as pilot trials. These research-based projects permit regional adult-use cannabis commerce at a local level to help lawmakers and regulators gather data and information to be better informed when crafting national laws and industry policies.

Current European Union agreements prohibit national commerce models like what is found in the Western Hemisphere, however, EU agreements do permit recreational commerce projects for public health research purposes. Pilot trials are currently operating in the Netherlands and Switzerland, and soon, trials are expected to launch in Germany.

In the video at this link, you can watch a recent presentation from the International Cannabis Business Conference in Berlin about European cannabis pilots. The panel was moderated by leading cannabis policy expert and attorney Kai-Friedrich Niermann, Founder of KFN+ Law Office. The panel also included:

  • Daniel S. Hübner, Senior Science Manager at the Cannabis Research Lab Humboldt-Universität zu Berlin
  • Finn A. Hänsel, Managing Director and a Founder of Sanity Group
  • Deepak Anand, Principal at ASDA Consultancy Services

Until EU agreements are modernized, cannabis pilot trials will continue to serve as an important legal commerce concept for EU member nations to consider.

European Cannabis Reform Demonstrations Scheduled For May 31st

Cannabis activism comes in many forms. Working to modernize cannabis policies in any jurisdiction where prohibition is in place is not easy and requires a diversity of tactics. One of those tactics that activists have incorporated for decades is public demonstrations and protests.

Peaceful protests and demonstrations are necessary in jurisdictions where people in power refuse to be sensible about cannabis policy and reform discussions. When policymakers are committed to ignoring or gaslighting cannabis advocates when they call for sensible laws and regulations, it is time for the masses to take to the public spaces, have their voices heard, and remind society that the cannabis movement is large and passionate.

There are at least two demonstrations scheduled to take place on Saturday, May 31st, in Europe. The first is a demonstration in Rome, Italy. DolceVita describes the demonstration as (translated from Italian to English) “the demands against the Security decree join those of hemp in demonstration with the presence of the Million Marijuana March.”

“Thousands of people will descend on Piazza Vittorio to say no to the Security decree, which, among other things, risks wiping out the Italian industrial hemp sector with a single stroke.” DolceVita also reported. “The one organized by Rete No Ddl Sicurezza and Million Marijuana March is much more than a demonstration. But one of the last opportunities to try to stop a law that, if definitively approved, would decree the closure of over 3 thousand companies and the dismissal of over 22 thousand workers.”

“The reasons for this massive mobilization are rooted in deep concerns about what will happen to the country’s hemp sector. The issue is not only economic, but also social. Announced crackdown on hemp could lead to closure of thousands of legal businesses; it may result in job losses and a subsequent rise of the black market.” reports Soft Secrets about the upcoming demonstration in Rome.

“Italy’s government passed the new Decree Law on Citizen Security on April 4, 2025, promoted by the leading Fratelli d’Italia conservative right-wing party and Prime Minister, Giorgia Meloni. The measure imposes rigid restrictions that will severely impact Italy’s industrial hemp sector and CBD products – one of the biggest in Europe.” the outlet also wrote.

The second demonstration will be held in Lisbon, Portugal. The Lisbon demonstration is reportedly organized by the March for Cannabis Collective, and is scheduled to start at 15:30 pm at Jardim das Amoreiras. Attendees will be advocating for the full legalization and regulation of recreational, medical, and industrial cannabis use.

“The March for Cannabis will be taking place in the heart of Lisbon next Saturday, in an event that usually brings together a large part of society that advocates for a change in the framework of cannabis.” reports CannaReporter. “The event, scheduled for 15:30 pm, will be held at Jardim das Amoreiras. At 16:20 pm, the March will begin its route towards Largo de Camões, in a walk that unites activists, patients, hemp farmers and even tourists in a single voice calling for legislative change.”

Check with local activists and organizations in your area to see if any demonstrations are being planned in your region on May 31st, and as always, keep fighting for sensible cannabis policies and regulations where you live by educating policymakers and nonpolicymakers about the benefits of modernized cannabis policies and the harms of prohibition.

Cannabis And Hemp Tourism Is A Growth Engine

The concept of people traveling to faraway destinations to enjoy consuming food and wine is not a new thing. Television shows are dedicated to the activity, and massive subsectors of the tourism industry are built around the concept. The same is proving to be true for cannabis and hemp tourism at an increasing rate.

A multi-year survey conducted by MMGY Travel Intelligence discovered that the cannabis travel audience in the United States alone includes roughly 72 million Americans, or 37% of the active leisure travel audience in the United States.

“Half of these interested travelers would consider visiting a cannabis shop, and a quarter of them are not regular cannabis users but are open to such experiences while traveling.” reported Travel Age West about the survey results.

In 2023, inbound tourism spending in Europe was an estimated 645 billion euros. At the intersection of these industries – cannabis, hemp, and travel – are opportunities for growth and creative differentiation.

Medical tourism, leisure travel, events, and business travel, including group meetings and conferences, are all part of it. Cannabis travel expert Brian Applegarth of Applegarth Strategies recently moderated a panel dedicated to cannabis and hemp tourism at the International Cannabis Business Conference in Berlin. Mr. Applegarth was joined by:

  • Mara Gordon – Co-Founder, Aunt Zelda’s, Octopi Wellness, Zelira Therapeutics
  • Jim Zielinski – General Manager, The Bulldog Hotel
  • Cristina Sánchez – Full Professor of Biochemistry and Molecular Biology at Complutense University
  • Ivan Ross Vrána – Managing Partner, Diplomat Consulting
  • Teddy Cabugos – President, Director, Sunstone Winery

Click here to watch a video of the ninety-minute presentation and panel discussion unpacking the tourism opportunities for cannabis and hemp businesses and brands in the European market.

The German Medical Cannabis Industry Is The Main European Market Driver

Germany first legalized medical cannabis in 2017, and its distribution model involves permitting legal sales at registered pharmacies. Germany’s medical cannabis industry has become the largest legal market in Europe, boosting the nation’s pharmacy sector in the process. Since the launch of initial sales, safe access to medical cannabis via Germany’s pharmacies has increased dramatically, as demonstrated by statistics that were included in a recent newsletter by the German Cannabis Business Association (BvCW).

“Patients can order cannabis online with a private prescription and have it delivered to their home. Nationwide, around 2,500 of the 17,000 pharmacies now offer medical cannabis,” BvCW stated (translated from German to English). “The industry’s revenue is now estimated at around half a billion euros.”

A major contributing factor to Germany’s recent medical cannabis industry growth was the enactment of the CanG law in April 2024, which removed cannabis from the nation’s Narcotics List. The rise of telemedicine has also contributed to the medical cannabis industry’s growth in Germany. A recent newsletter by leading international cannabis economist Beau Whitney, founder of Whitney Economics, provides some reliable market data regarding the current estimated number of medical cannabis patients in Germany.

“There has been a consistent number of between 200k – 300k medical patients.” Beau Whitney writes. “As a result of this new innovation, there is now an additional 500k – 600k self-paying consumers participating in the legal market.”

“When combined with 100k cultivation association members, there is approximately 800k legal consumers in the German market right now. For perspective, 800k consumers represents between 10% and 20% of the total market, while the supply and capacity at the end of 2024 represented nearly 15% of all of the supply that the market needs.” Whitney stated.

At the recent International Cannabis Business Conference in Berlin, a team of experts from Germany’s emerging medical cannabis industry examined how the nation’s medical market is the main overall market driver in Europe. The panel was moderated by Canadian medical cannabis pioneer Alex Revich and included:

  • Torsten Greif, CEO, Four 20 Pharma
  • Benedikt Sons, Co-Founder and CEO, Cansativa Group
  • Matthias Fischer, Founder and Managing Director, Canymed, CCO, Grünhorn
  • Dr. rer. nat. Adrian Fischer, Physician and Natural Scientist, Co-Founder and Managing Director, DEMECAN

Click here to watch a video of the panel discussion.